The trial, sponsored by City of Hope Medical Center, assesses the feasibility of an app-based mindfulness intervention for patients with metastatic renal cell carcinoma (mRCC). Given the increasing focus on mental health and quality of life in oncology, this intervention could represent a novel approach to supportive care in cancer treatment. The market for digital health solutions, particularly in cancer care, is expanding, with significant interest from both patients and healthcare providers. If successful, the findings could lead to broader applications of mindfulness interventions in oncology, potentially positioning the app as a complementary tool in cancer care protocols. Competitive implications include the need to monitor similar digital health initiatives targeting psychosocial support in oncology, as well as the potential for partnerships with healthcare systems and payers to integrate such solutions into standard care pathways.